查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1751020

2025年全球人類類器官市場報告

Human Organoids Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年人類類器官市場規模將快速成長。 2029年，該市場規模將成長至31.5億美元，複合年成長率為16.5%。預測期內的成長歸因於對基於類器官的疾病建模需求的不斷成長、生物技術研究投入的不斷增加、藥物篩檢應用的不斷擴展、毒理學研究應用的日益普及以及對精準醫療日益成長的興趣。預測期內的主要趨勢包括人工智慧的整合、患者特異性類器官的開發、基因治療應用的擴展、類器官生物列印的進步以及3D細胞培養技術的進步。

預計基因研究實驗的增加將推動研究市場的成長。基因科學關注性狀如何透過基因遺傳以及遺傳訊息如何影響生物體的發育和功能，由於技術進步使得基因編輯更快、更精確，實驗數量正在增加。這些突破使得對疾病的研究更加深入和開發有針對性的治療方法成為可能。在人體類器官的背景下，基因科學可以精確地操縱基因來模擬特定疾病並研究其進展。這有助於研究人員更了解遺傳疾病、測試新藥並探索個人化治療策略。例如，根據美國醫學研究機構國立衛生研究院 (NIH) 2023 年 4 月的報告，截至 2022 年 11 月，美國共註冊了 129,624 項基因測試，約佔全球基因測試註冊中心 (GTR) 註冊的所有測試的 66%。因此，基因研究實驗數量的增加將有助於人體類器官市場的成長。

為了提高體外模型的生理相關性，人類類器官市場的主要企業正專注於開發先進的幹細胞技術，例如新一代3D組織培養平台。新一代3D組織培養平台是先進的體外系統，旨在比傳統的2D和早期的3D模型更準確地再現人體組織的複雜性。例如，2022年10月，AIM Biotech Pte. Ltd.推出了先進的3D組織培養系統organiX。該系統旨在透過整合類器官、功能性血管系統和免疫細胞成分，更準確地再現人類疾病狀況。該平台專為尖端藥物開發和個人化醫療量身定做，可在可控且生理相關的環境中容納各種組織形式，包括類器官和腫瘤樣本。它支援免疫共培養，實現即時高解析度成像，並有助於組織恢復以供下游分析。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球人類類器官 PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球人體類器官市場：成長率分析
  • 全球人體類器官市場表現：規模與成長，2019-2024
  • 全球人體類器官市場預測：2024-2029年及2034年規模與成長
  • 全球人類類器官總目標市場（TAM）

第6章市場區隔

  • 全球人體類器官市場類型、表現及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 腦類器官
  • 心臟類器官
  • 腸道類器官
  • 腎臟類器官
  • 肝臟類器官
  • 肺類器官
  • 胰臟類器官
  • 全球人體類器官市場（按技術、性能和預測）：2019-2024 年、2024-2029 年、2034 年
  • 3D生物列印
  • 細胞培養技術
  • 水凝膠和基於支架的技術
  • 磁浮
  • 全球人體類器官市場：應用、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 藥物研發
  • 感染疾病監測
  • 神經學研究
  • 腫瘤監測
  • 個人化醫療
  • 再生醫學
  • 全球人體類器官市場：依最終使用者、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 製藥和生物技術公司
  • 合約研究組織
  • 學術研究所
  • 全球人類類器官市場腦類器官細分（依類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 腦類器官
  • 中腦類器官
  • 下視丘類器官
  • 脊髓類器官
  • 全球人體類器官市場心臟類器官細分（依類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 心臟類器官
  • 血管化心臟類器官
  • 心室特異性心臟類器官
  • 全球人體類器官市場腸道類器官細分（按類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 小腸類器官
  • 結腸類器官
  • 十二指腸類器官
  • 全球人體類器官市場腎臟類器官細分（依類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 腎元類器官
  • 腎絲球類器官
  • 近端小管類器官
  • 全球人體類器官市場肝臟類器官細分（依類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 肝臟類器官
  • 膽管類器官
  • 膽管細胞類器官
  • 全球人體類器官市場肺類器官細分（依類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 氣道類器官
  • 肺泡類器官
  • 支氣管類器官
  • 全球人體類器官市場：胰臟類器官細分（按類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 胰島類器官
  • 管狀胰臟類器官
  • 胰腺腺泡類器官

第7章 區域和國家分析

  • 全球人體類器官市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球人體類器官市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 人體類器官市場：競爭格局
  • 人體類器官市場：公司簡介
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Corning Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • Bio-Techne Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Organovo Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Emulate Inc.
  • MIMETAS BV
  • Cellink AB
  • InSphero AG
  • Kerafast Inc.
  • DefiniGEN Limited
  • Visikol Inc.
  • CN Bio Innovations Limited
  • Cannex Scientific Inc.
  • HeartBeat.bio AG
  • Kirkstall Ltd.
  • Cyprio Ltd.
  • 3Dnamics Inc.
  • BrainZell Ltd.
  • AIVITA Biomedical Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年人類類器官市場：提供新機會的國家
  • 2029年人類類器官市場：細分領域蘊含新機會
  • 2029年人體類器官市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r34873

Human organoids are powerful models for studying human biology, disease mechanisms, and testing drug responses in ways that mimic real human organs. The main types of human organoids, such as brain, heart, intestinal, kidney, liver, lung, and pancreatic organoids, allow researchers to investigate specific organ-related diseases and conditions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Brain organoids, for instance, are used in drug discovery, neurology studies, infectious disease research, oncology research, and personalized medicine. These organoids are created using cutting-edge technologies, such as 3D bioprinting, hydrogels, scaffold-based methods, and magnetic levitation, which help replicate the three-dimensional structure and function of human tissues. The primary users of these organoids include pharmaceutical and biotechnology companies, contract research organizations (CROs), and academic research institutions, which use these models for various applications ranging from disease modeling to drug testing and personalized therapeutic development.

The human organoids market research report is one of a series of new reports from The Business Research Company that provides human organoids market statistics, including human organoids industry global market size, regional shares, competitors with a human organoids market share, detailed human organoids market segments, market trends and opportunities, and any further data you may need to thrive in the human organoids industry. This human organoids market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The human organoids market size has grown rapidly in recent years. It will grow from $1.47 billion in 2024 to $1.71 billion in 2025 at a compound annual growth rate (CAGR) of 16.8%. The growth during the historic period can be attributed to a greater emphasis on personalized medicine, the rising prevalence of chronic diseases, advancements in regenerative medicine, the expansion of drug discovery applications, and the increase in government and private sector funding.

The human organoids market size is expected to see rapid growth in the next few years. It will grow to $3.15 billion in 2029 at a compound annual growth rate (CAGR) of 16.5%. The growth during the forecast period can be attributed to the rising demand for organoid-based disease modeling, increased investment in biotech research, expanding uses in drug screening, greater adoption in toxicology studies, and growing interest in precision medicine. Key trends in the forecast period include the integration of artificial intelligence, the development of patient-specific organoids, expansion into gene therapy applications, advancements in organoid bioprinting, and technological progress in 3D cell culture.

The growing number of genetic research experiments is expected to drive the growth of the human organoids market. Genetic science, which focuses on how traits are inherited through genes and how genetic information influences the development and functioning of organisms, is seeing an increase in experiments due to technological advancements that make gene editing faster and more accurate. These breakthroughs enable deeper research into diseases and the development of targeted treatments. In the context of human organoids, genetic science allows for precise manipulation of genes to model specific diseases and study their progression. This helps researchers better understand genetic disorders, test new drugs, and explore personalized treatment strategies. For example, in April 2023, a report by the National Institutes of Health (NIH), a US-based medical research agency, noted that by November 2022, the U.S. had registered 129,624 genetic tests, accounting for approximately 66% of all tests in the worldwide Genetic Testing Registry (GTR). As such, the rising number of genetic research experiments will contribute to the growth of the human organoids market.

Leading companies in the human organoids market are focusing on developing advanced stem cell technologies, such as next-generation 3D tissue culture platforms, to enhance the physiological relevance of in vitro models. A next-generation 3D tissue culture platform is an advanced in vitro system designed to more accurately replicate the complexity of human tissues compared to traditional 2D or earlier 3D models. For instance, in October 2022, AIM Biotech Pte. Ltd., a Singapore-based developer of tissue culture chips, introduced organiX, an advanced 3D tissue culture system. This system is designed to more accurately replicate human disease conditions by integrating organoids, functional vasculature, and immune cell components. The platform is tailored for cutting-edge drug development and personalized medicine, accommodating various tissue formats, such as organoids and tumor samples, within a controllable and physiologically relevant environment. It supports immune co-culture, allows real-time high-resolution imaging, and facilitates easy tissue retrieval for downstream analyses.

In January 2025, Merck Group, a Germany-based pharmaceutical company, acquired HUB Organoids Holding B.V. for an undisclosed amount. This acquisition aims to bolster Merck's next-generation biology portfolio by incorporating advanced organoid technology. This will accelerate drug development, provide deeper insights into treatments across various populations, and reduce the need for animal testing, aligning with Merck's commitment to innovative and ethical life sciences solutions. HUB Organoids Holding B.V., based in the Netherlands, specializes in human organoid research and applications.

Major players in the human organoids market are Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Corning Incorporated, Bio-Techne Corporation, Organovo Holdings Inc., Emulate Inc., MIMETAS B.V., Cellink AB, InSphero AG, Kerafast Inc., DefiniGEN Limited, Visikol Inc., CN Bio Innovations Limited, Cannex Scientific Inc., HeartBeat.bio AG, Kirkstall Ltd., Cyprio Ltd., 3Dnamics Inc., BrainZell Ltd., AIVITA Biomedical Inc.

North America was the largest region in the human organoids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in human organoids report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the human organoids market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The human organoids market include revenues earned by entities by providing services such as drug discovery and development, disease modeling, toxicology testing, regenerative medicine research, and biomarker discovery. The market value includes the value of related goods sold by the service provider or included within the service offering. The human organoids market also consists of sales of products including organoid-based therapeutics, disease modeling solutions, drug testing platforms, and research applications. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Human Organoids Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on human organoids market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for human organoids ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The human organoids market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Brain Organoids; Heart Organoids; Intestinal Organoids; Kidney Organoids; Liver Organoids; Lung Organoids; Pancreatic Organoids
  • 2) By Technology: 3D Bioprinting; Cell Culture Technology; Hydrogels And Scaffold-Based Technology; Magnetic Levitation
  • 3) By Application: Drug Discovery; Infectious Disease Research; Neurology Studies; Oncology Research; Personalized Medicine; Regenerative Medicine
  • 4) By End User: Pharma And Biotech Companies; Contract Research Organizations; Academic And Research Institutes
  • Subsegments:
  • 1) By Brain Organoids: Cerebral Organoids; Midbrain Organoids; Hypothalamic Organoids; Spinal Cord Organoids
  • 2) By Heart Organoids: Cardiac Muscle Organoids; Vascularized Heart Organoids; Chamber-Specific Heart Organoids
  • 3) By Intestinal Organoids: Small Intestine Organoids; Colon Organoids; Duodenal Organoids
  • 4) By Kidney Organoids: Nephron Organoids; Glomerular Organoids; Proximal Tubule Organoids
  • 5) By Liver Organoids: Hepatic Organoids; Bile Duct Organoids; Cholangiocyte Organoids
  • 6) By Lung Organoids: Airway Organoids; Alveolar Organoids; Bronchial Organoids
  • 7) By Pancreatic Organoids: Islet Organoids; Ductal Pancreatic Organoids; Acinar Pancreatic Organoids
  • Companies Mentioned: Thermo Fisher Scientific Inc.; F. Hoffmann-La Roche Ltd.; Corning Incorporated; Bio-Techne Corporation; Organovo Holdings Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Human Organoids Market Characteristics

3. Human Organoids Market Trends And Strategies

4. Human Organoids Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Human Organoids Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Human Organoids PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Human Organoids Market Growth Rate Analysis
  • 5.4. Global Human Organoids Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Human Organoids Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Human Organoids Total Addressable Market (TAM)

6. Human Organoids Market Segmentation

  • 6.1. Global Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Brain Organoids
  • Heart Organoids
  • Intestinal Organoids
  • Kidney Organoids
  • Liver Organoids
  • Lung Organoids
  • Pancreatic Organoids
  • 6.2. Global Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 3D Bioprinting
  • Cell Culture Technology
  • Hydrogels And Scaffold-Based Technology
  • Magnetic Levitation
  • 6.3. Global Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Discovery
  • Infectious Disease Research
  • Neurology Studies
  • Oncology Research
  • Personalized Medicine
  • Regenerative Medicine
  • 6.4. Global Human Organoids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharma And Biotech Companies
  • Contract Research Organizations
  • Academic And Research Institutes
  • 6.5. Global Human Organoids Market, Sub-Segmentation Of Brain Organoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cerebral Organoids
  • Midbrain Organoids
  • Hypothalamic Organoids
  • Spinal Cord Organoids
  • 6.6. Global Human Organoids Market, Sub-Segmentation Of Heart Organoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiac Muscle Organoids
  • Vascularized Heart Organoids
  • Chamber-Specific Heart Organoids
  • 6.7. Global Human Organoids Market, Sub-Segmentation Of Intestinal Organoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Small Intestine Organoids
  • Colon Organoids
  • Duodenal Organoids
  • 6.8. Global Human Organoids Market, Sub-Segmentation Of Kidney Organoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nephron Organoids
  • Glomerular Organoids
  • Proximal Tubule Organoids
  • 6.9. Global Human Organoids Market, Sub-Segmentation Of Liver Organoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hepatic Organoids
  • Bile Duct Organoids
  • Cholangiocyte Organoids
  • 6.10. Global Human Organoids Market, Sub-Segmentation Of Lung Organoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Airway Organoids
  • Alveolar Organoids
  • Bronchial Organoids
  • 6.11. Global Human Organoids Market, Sub-Segmentation Of Pancreatic Organoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Islet Organoids
  • Ductal Pancreatic Organoids
  • Acinar Pancreatic Organoids

7. Human Organoids Market Regional And Country Analysis

  • 7.1. Global Human Organoids Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Human Organoids Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Human Organoids Market

  • 8.1. Asia-Pacific Human Organoids Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Human Organoids Market

  • 9.1. China Human Organoids Market Overview
  • 9.2. China Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Human Organoids Market

  • 10.1. India Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Human Organoids Market

  • 11.1. Japan Human Organoids Market Overview
  • 11.2. Japan Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Human Organoids Market

  • 12.1. Australia Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Human Organoids Market

  • 13.1. Indonesia Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Human Organoids Market

  • 14.1. South Korea Human Organoids Market Overview
  • 14.2. South Korea Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Human Organoids Market

  • 15.1. Western Europe Human Organoids Market Overview
  • 15.2. Western Europe Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Human Organoids Market

  • 16.1. UK Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Human Organoids Market

  • 17.1. Germany Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Human Organoids Market

  • 18.1. France Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Human Organoids Market

  • 19.1. Italy Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Human Organoids Market

  • 20.1. Spain Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Human Organoids Market

  • 21.1. Eastern Europe Human Organoids Market Overview
  • 21.2. Eastern Europe Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Human Organoids Market

  • 22.1. Russia Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Human Organoids Market

  • 23.1. North America Human Organoids Market Overview
  • 23.2. North America Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Human Organoids Market

  • 24.1. USA Human Organoids Market Overview
  • 24.2. USA Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Human Organoids Market

  • 25.1. Canada Human Organoids Market Overview
  • 25.2. Canada Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Human Organoids Market

  • 26.1. South America Human Organoids Market Overview
  • 26.2. South America Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Human Organoids Market

  • 27.1. Brazil Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Human Organoids Market

  • 28.1. Middle East Human Organoids Market Overview
  • 28.2. Middle East Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Human Organoids Market

  • 29.1. Africa Human Organoids Market Overview
  • 29.2. Africa Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Human Organoids Market Competitive Landscape And Company Profiles

  • 30.1. Human Organoids Market Competitive Landscape
  • 30.2. Human Organoids Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Corning Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Bio-Techne Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Organovo Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Human Organoids Market Other Major And Innovative Companies

  • 31.1. Emulate Inc.
  • 31.2. MIMETAS B.V.
  • 31.3. Cellink AB
  • 31.4. InSphero AG
  • 31.5. Kerafast Inc.
  • 31.6. DefiniGEN Limited
  • 31.7. Visikol Inc.
  • 31.8. CN Bio Innovations Limited
  • 31.9. Cannex Scientific Inc.
  • 31.10. HeartBeat.bio AG
  • 31.11. Kirkstall Ltd.
  • 31.12. Cyprio Ltd.
  • 31.13. 3Dnamics Inc.
  • 31.14. BrainZell Ltd.
  • 31.15. AIVITA Biomedical Inc.

32. Global Human Organoids Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Human Organoids Market

34. Recent Developments In The Human Organoids Market

35. Human Organoids Market High Potential Countries, Segments and Strategies

  • 35.1 Human Organoids Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Human Organoids Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Human Organoids Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
  • 250617_r34873_Human_Organoids_GMR_2025